Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 98, Issue 8, 2004, Pages 496-504

  Kamgno, Joseph ^a   Gardon, Jacques ^a   Gardon Wendel, Nathalie ^a   Demanga Ngangue, A ^b   Duke, Brian O L ^c   Boussinesq, Michel ^a,d  

^a CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^b Delegation Provinciale de la Sante Publique du Littoral   (Cameroon)

^c River Blindness Foundation   (United Kingdom)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Cameroon; Clinical trial; Ivermectin; Onchocerca volvulus; Onchocerciasis; Tolerance

Indexed keywords

IVERMECTIN; PLACEBO;

ABDOMINAL DISEASE; ADULT; ANOREXIA; ARTHRALGIA; ARTICLE; ASTHENIA; BACKACHE; CAMEROON; CLINICAL TRIAL; COLD SENSATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE TRANSMISSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG MEGADOSE; EDEMA; EYE DISEASE; FEASIBILITY STUDY; FEVER; HEADACHE; HUMAN; INSOMNIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; NAUSEA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARESTHESIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SIDE EFFECT; SKIN MANIFESTATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THORAX PAIN; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANIMALS; ANTHELMINTICS; DOUBLE-BLIND METHOD; HUMANS; IVERMECTIN; MALE; MIDDLE AGED; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; RISK FACTORS;

ONCHOCERCA; ONCHOCERCA VOLVULUS;

EID: 3242718017     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2003.10.018     Document Type: Article

References (19)

1. Awadzi K Dadzie K.Y De Sole G Remme J Reactions to ivermectin treatment in onchocerciasis patients Acta Leiden. 59 1990 193-199
2. Awadzi K Opoku N.O Addy E.T Quartey B.T The chemotherapy of onchocerciasis XIX: the clinical and laboratory tolerance of high dose ivermectin Trop. Med. Parasitol. 46 1995 131-137
3. Awadzi K Attah S.K Addy E.T Opoku N.O Quartey B.T The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients Trans. R. Soc. Trop. Med. Hyg. 93 1999 189-194
4. Boussinesq M Gardon J Kamgno J Pion S.D.S Gardon-Wendel N Chippaux J.P Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon Ann. Trop. Med. Parasitol. 95 2001 495-507
5. Brattig N.W Büttner D.W Hoerauf A Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria Microbes Infect. 3 2001 439-446
6. Cooper P.J Awadzi K Ottesen E.A Remick D Nutman T.B Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin J. Infect. Dis. 179 1999 738-742
7. Cooper P.J Beck L.A Espinel I Deyampert N.M Hartnell A Jose P.J Paredes W Guderian R.H Nutman T.B Eotaxin and RANTES expression by the dermal endothelium is associated with eosinophil infiltration after ivermectin treatment of onchocerciasis Clin. Immunol. 95 2000 51-61
8. De Sole G Remme J Awadzi K Accorsi S Alley E.S Ba O Dadzie K.Y Giese J Karam M Keita F.M Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials Bull. World Health Organ. 67 1989 707-719
9. Duke B.O.L Zea-Flores G Muñoz B The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin Trop. Med. Parasitol. 42 1991 175-180
10. Gardon J Gardon-Wendel N Demanga-Ngangue Kamgno J Chippaux J.P Boussinesq M Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection Lancet 350 1997 18-22
11. Gardon, J., Boussinesq, M., Kamgno, J., Gardon-Wendel, N., Demanga-Ngangue, Duke, B.O.L., 2002. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet 360, 203-210.
12. Keiser P.B Reynolds S.M Awadzi K Ottesen E.A Taylor M.J Nutman T.B Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions J. Infect. Dis. 185 2002 805-811
13. Macé J.M Boussinesq M Ngoumou P Enyegue Oye J Koéranga A Godin C Country-wide rapid epidemiological mapping of onchocerciasis (REMO) in Cameroon Ann. Trop. Med. Parasitol. 91 1997 379-391
14. Njoo F.L Hack C.E Oosting J Stilma J.S Kijlstra A Neutrophil activation in ivermectin-treated onchocerciasis patients Clin. Exp. Immunol. 94 1993 330-333
15. Njoo F.L Hack C.E Oosting J Luyendijk L Stilma J.S Kijlstra A C-reactive protein and interleukin-6 are elevated in onchocerciasis patients after ivermectin treatment J. Infect. Dis. 170 1994 663-668
16. Plaisier A.P Alley E.S Boatin B.A Van Oortmarssen G.J Remme H De Vlas S.J Bonneux L Habbema J.D.F Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa J. Infect. Dis. 172 1995 204-210
17. Prod'hon J Boussinesq M Fobi G Prud'hom J.M Enyong P Lafleur C Quillévéré D Lutte contre l'onchocercose par ivermectine: résultats d'une campagne de masse au Nord-Cameroun Bull. World Health Organ. 69 1991 443-450
18. WHO, 1995. Onchocerciasis and its control. World Health Organization, Geneva, Technical Report Series No. 852.
19. Winnen M Plaisier A.P Alley E.S Nagelkerke N.J.D van Oortmarssen G Boatin B.A Habbema J.D.F Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull. World Health Organ. 80 2002 384-390